JPH0344381A - Optically active oxazolidinone derivative - Google Patents
Optically active oxazolidinone derivativeInfo
- Publication number
- JPH0344381A JPH0344381A JP1179493A JP17949389A JPH0344381A JP H0344381 A JPH0344381 A JP H0344381A JP 1179493 A JP1179493 A JP 1179493A JP 17949389 A JP17949389 A JP 17949389A JP H0344381 A JPH0344381 A JP H0344381A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- optically active
- formula
- amino
- benzyloxypropan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title claims description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 13
- SRLIILIYNJEOSN-UHFFFAOYSA-N 5-(phenylmethoxymethyl)-1,3-oxazolidin-2-one Chemical class O1C(=O)NCC1COCC1=CC=CC=C1 SRLIILIYNJEOSN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003054 catalyst Substances 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 6
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- QNYBOILAKBSWFG-UHFFFAOYSA-N 2-(phenylmethoxymethyl)oxirane Chemical compound C1OC1COCC1=CC=CC=C1 QNYBOILAKBSWFG-UHFFFAOYSA-N 0.000 abstract description 12
- ZGHLNQMMKJNJIH-UHFFFAOYSA-N 1-amino-3-phenylmethoxypropan-2-ol Chemical class NCC(O)COCC1=CC=CC=C1 ZGHLNQMMKJNJIH-UHFFFAOYSA-N 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 238000007327 hydrogenolysis reaction Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000002177 Cataract Diseases 0.000 abstract description 2
- 239000002876 beta blocker Substances 0.000 abstract description 2
- 229940097320 beta blocking agent Drugs 0.000 abstract description 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 2
- CWZRNUYTFMYGGA-UHFFFAOYSA-N 3-(phenylmethoxymethyl)-1,3-oxazolidin-2-one Chemical class O=C1OCCN1COCC1=CC=CC=C1 CWZRNUYTFMYGGA-UHFFFAOYSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 230000036543 hypotension Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 15
- LSYOFPBORRARMF-UHFFFAOYSA-N 5-(hydroxymethyl)-1,3-oxazolidin-2-one Chemical class OCC1CNC(=O)O1 LSYOFPBORRARMF-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 150000002431 hydrogen Chemical group 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FJXVYZMGZACQOS-JTQLQIEISA-N (2r)-1-chloro-3-phenylmethoxypropan-2-ol Chemical compound ClC[C@H](O)COCC1=CC=CC=C1 FJXVYZMGZACQOS-JTQLQIEISA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- -1 alkyl chlorocarbonate Chemical compound 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QNYBOILAKBSWFG-JTQLQIEISA-N (2r)-2-(phenylmethoxymethyl)oxirane Chemical compound C([C@@H]1OC1)OCC1=CC=CC=C1 QNYBOILAKBSWFG-JTQLQIEISA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FJXVYZMGZACQOS-UHFFFAOYSA-N 1-chloro-3-phenylmethoxypropan-2-ol Chemical compound ClCC(O)COCC1=CC=CC=C1 FJXVYZMGZACQOS-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- KJBPYIUAQLPHJG-UHFFFAOYSA-N 1-phenylmethoxypropan-2-ol Chemical compound CC(O)COCC1=CC=CC=C1 KJBPYIUAQLPHJG-UHFFFAOYSA-N 0.000 description 1
- RXRVCSDDGFQDOJ-UHFFFAOYSA-N 5-(hydroxymethyl)-3-propan-2-yl-1,3-oxazolidin-2-one Chemical compound CC(C)N1CC(CO)OC1=O RXRVCSDDGFQDOJ-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 101150064474 NOP58 gene Proteins 0.000 description 1
- 101150064053 Rffl gene Proteins 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000002344 gold compounds Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は光学活性オキサゾリジノン誘導体の製法に関す
る。この誘導体は抗不整脈、血圧降下。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a method for producing optically active oxazolidinone derivatives. This derivative is antiarrhythmic and blood pressure lowering.
白内障の治療薬として有用な光学活性βブロッカ−の原
料として有用な化合物である。This compound is useful as a raw material for optically active β-blockers useful as therapeutic agents for cataracts.
(従来技術と発明が解決しようとする課題)従来、一般
式(4)
(式(4)中R1は水素、01〜CT2のアルキル基、
又はアラルキル基を表わし、*は不斉炭素を表わす。〉
で示される光学活性オキサゾリジノン誘導体は下記反応
経路(I)で示される光学活性グリセルアルデヒドを経
由する方法(A) (Chem、 Pharm、 B
u l t 、 、 29.3593(1981)、津
田喜典等)やラセミ体の、微生物による不斉氷解(B)
(待開昭60−36471等〉、3−アミノ−1,2−
オキシプロパン誘導体を経由する方法(C) (特開[
1360−67470>等が知られている。(Prior art and problems to be solved by the invention) Conventionally, general formula (4) (in formula (4), R1 is hydrogen, an alkyl group of 01 to CT2,
or represents an aralkyl group, and * represents an asymmetric carbon. 〉
The optically active oxazolidinone derivative represented by can be obtained by the method (A) via optically active glyceraldehyde shown in the following reaction route (I) (Chem, Pharm, B
Asymmetric ice thawing by microorganisms of ul t, , 29.3593 (1981), Yoshinori Tsuda et al.) and racemates (B)
(Machikai Sho 60-36471, etc.), 3-amino-1,2-
Method (C) via oxypropane derivative (Unexamined Japanese Patent Publication [
1360-67470> etc. are known.
く
■
○
しかしながら(A>では原料の光学活性グリセルアルデ
ヒドが、D−マンニトールから多段階で合成せねばなら
ず、しかもラセミ化をしやすい為取扱いが難しいし、(
B)では基質濃度をあまり高くできず、反対の立体配置
の未反応エステルとの分離が必要である等の問題があり
、(C)では3−アミノ−1,2−オキシプロパン誘導
体を合成するのに副反応をともなう数段階の反応を要し
、しかも3−アミノ−1,2−オキシプロパン誘導体自
体不安定で取扱いが難しい化合物であるという欠点をか
かえている。○ However, in (A>), the raw material optically active glyceraldehyde must be synthesized from D-mannitol in multiple steps, and it is difficult to handle because it is easily racemized.
In B), there are problems such as the substrate concentration cannot be made very high and it is necessary to separate the unreacted ester with the opposite configuration, and in (C), a 3-amino-1,2-oxypropane derivative is synthesized. However, it requires several steps of reaction accompanied by side reactions, and furthermore, the 3-amino-1,2-oxypropane derivative itself has the drawback of being an unstable compound and difficult to handle.
(課題を解決するための手段)
本発明者は上記の方法にかわる光学活性オキサゾリジノ
ン誘導体の製法を見出すべく鋭意検討した結果、下記反
応経路(II)に従い、光学活性ベンジルグリシジルエ
ーテル(0)から光学純度の高い光学活性オキサゾリジ
ノン誘導体(4)が容易に得られることを見出した。(Means for Solving the Problems) As a result of intensive studies to find a method for producing optically active oxazolidinone derivatives in place of the above-mentioned method, the inventors of the present invention determined that optically active benzyl glycidyl ether (0) was It has been found that a highly pure optically active oxazolidinone derivative (4) can be easily obtained.
区
本発明はこの反応経路に従って得られる誘導体(4)を
提供するものである。The present invention provides a derivative (4) obtained according to this reaction route.
すなわち本発明は一般式(3)
(式中phはフェニル基を、R1は水素、01〜Crz
のアルキル基、アリール基又はアラルキル基を表わし、
*は不斉炭素を表わす。)で表わされる5−ベンジルオ
キシメチルオキサゾリジン−2−オン誘導体(3)をパ
ラジウム触媒の存在下水素化分解することを特徴とする
、一般式(4)(式中R1,*は上記と同じ。)で表わ
される光学活性オキサゾリジノン誘導体(4)の製法で
ある。That is, the present invention relates to general formula (3) (wherein ph is a phenyl group, R1 is hydrogen, 01 to Crz
represents an alkyl group, aryl group or aralkyl group,
* represents an asymmetric carbon. ) 5-benzyloxymethyloxazolidin-2-one derivative (3) represented by the general formula (4) (where R1 and * are the same as above) is hydrogenolyzed in the presence of a palladium catalyst. ) is a method for producing an optically active oxazolidinone derivative (4).
以下反応経路(It>に従って化合物(0)より出発し
て誘導体(3)より誘導体(4)を合成する方法を説明
する。A method for synthesizing derivative (4) from derivative (3) starting from compound (0) according to reaction route (It>) will be described below.
a〉光学活性ベンジルグリシジルエーテル(0)若しく
は1−ベンジルオキシ−3−クロロ−プロパン−2−オ
ールの合成
ここで原料として用いるベンジルグリシジルエーテル(
0)は光学純度の高いものが要求されるが、これは光学
純度98%ee以上のエピクロルヒドリンをトリフルオ
ロボロンエーテル錯体なとのルイス酸触媒の存在下でベ
ンジルアルコールと反応させて得られる光学活性な1−
ベンジルオキシ−3−クロロ−プロパン−2−オールを
苛性ソーダなどで処理して得ることができる。a> Synthesis of optically active benzyl glycidyl ether (0) or 1-benzyloxy-3-chloro-propan-2-ol benzyl glycidyl ether (0) used as a raw material here
0) is required to have high optical purity, and this is an optically active product obtained by reacting epichlorohydrin with an optical purity of 98% ee or higher with benzyl alcohol in the presence of a Lewis acid catalyst such as a trifluoroboron ether complex. Na1-
It can be obtained by treating benzyloxy-3-chloro-propan-2-ol with caustic soda or the like.
b)1−アミノ−3−ベンジルオキシプロパン−2−オ
ール誘導体(1〉の合成
ベンジルグリシジルエーテル(0)と、アミンの反応は
アミン量が少いと生成した1−アミノ−3−ベンジルオ
キシプロパン−2−オール誘導体(1)へ更にベンジル
グリシジルエーテルが反応するため、5倍当量以上、よ
り好ましくは10倍当量以上のア且ンと反応させる必要
がある。またアミンがイソプロピルアミンなどの様に沸
点の低い場合は水、メタノール、エタノールなどの溶媒
を混合して沸点を上げてやることが好ましい。b) Synthesis of 1-amino-3-benzyloxypropan-2-ol derivative (1) The reaction between benzyl glycidyl ether (0) and an amine produces 1-amino-3-benzyloxypropan-2-ol when the amount of amine is small. Since benzyl glycidyl ether further reacts with the 2-ol derivative (1), it is necessary to react with 5 times equivalent or more, more preferably 10 times equivalent or more of ane.Also, the amine has a boiling point such as isopropylamine. If the boiling point is low, it is preferable to mix a solvent such as water, methanol, or ethanol to raise the boiling point.
この光学活性な1−アミノ−3−ベンジルオキシプロパ
ン−2−オール誘導体(1)は上記の光学活性な1−ベ
ンジルオキシ−3−クロロプロパン−2−オールをアミ
ン当量以上と加熱還流下に反応させることによっても得
られる。この場合生成物は光学活性な1−アミノ−3−
ベンジルオキシプロパン−2−オールの塩@塩であるの
で、反応途中あるいは反応終了後炭酸ナトリウム、炭酸
カリウムなどの塩基1〜5モルを加えて後処理をし、遊
離のアミンを得ることができる。This optically active 1-amino-3-benzyloxypropan-2-ol derivative (1) is obtained by reacting the above-mentioned optically active 1-benzyloxy-3-chloropropan-2-ol with an equivalent or more of the amine under heating under reflux. It can also be obtained by In this case, the product is an optically active 1-amino-3-
Since it is a salt of benzyloxypropan-2-ol, a free amine can be obtained by post-treatment by adding 1 to 5 moles of a base such as sodium carbonate or potassium carbonate during or after the reaction.
C)1−(N−アルコキシカルボニル)アミノ−3−ベ
ンジルオキシプロパン−2−オール誘導体(2〉の合成
1−アミノ−3−ベンジルオキシプロパン−2−オール
誘導体(1〉ととクロロ炭酸アルキルとの反応は二級水
酸基へのオキシカルボニル化を抑制するために一り5℃
〜室温の範囲でクロロ炭酸アルキルを徐々に加えること
が望ましい。クロロ炭酸アルキルエステルとしてはメチ
ル、エチル。C) Synthesis of 1-(N-alkoxycarbonyl)amino-3-benzyloxypropan-2-ol derivative (2) 1-amino-3-benzyloxypropan-2-ol derivative (1) and alkyl chlorocarbonate The reaction was carried out at 5°C to suppress oxycarbonylation to secondary hydroxyl groups.
It is desirable to gradually add the alkyl chlorocarbonate at temperatures ranging from ~room temperature. Methyl and ethyl chlorocarbonate alkyl esters.
ベンジルなどのアルキルエステルを用いることができる
。量的には1.0〜1,4当量が望ましい。Alkyl esters such as benzyl can be used. In terms of quantity, 1.0 to 1.4 equivalents are desirable.
受酸剤としての塩基は1〜10倍当量用いることができ
、炭酸ナトリウム、炭酸カリウム、炭M1ノチウム、炭
酸バリウム、炭酸マグネシウム、炭酸水素ナトリウムな
どの炭酸塩が好ましい。溶媒はアセトン、ジオキサン、
テトラヒドロフラン、エチレングリコールジメチルエー
テル、 N、N−ジメチルホルムアルデヒド、ジメチ
ルスルホキシド。The base as an acid acceptor can be used in an amount of 1 to 10 times equivalent, and carbonates such as sodium carbonate, potassium carbonate, carbon M1 notium, barium carbonate, magnesium carbonate, and sodium hydrogen carbonate are preferred. Solvents are acetone, dioxane,
Tetrahydrofuran, ethylene glycol dimethyl ether, N,N-dimethyl formaldehyde, dimethyl sulfoxide.
エタノール、メタノールなどの極性溶媒を用いることが
できる。塩基として用いる炭酸塩を溶解するために、水
を添加することもできる。Polar solvents such as ethanol and methanol can be used. Water can also be added to dissolve the carbonate used as base.
d)オキサゾリジン−2−オン誘導体(3)の合成
オキサゾリジン−2−オン誘導体(3)への閉環反応は
N、N−ジメチルホルムアルデヒド、 N、N−ジメ
チルアセトアルデヒド。ジエチレングリコールジエチル
エーテル、N−メチルピロリドンなどの極性溶媒中、炭
酸ナトリウムや炭酸カリウムと加熱還流することにより
達成できる。d) Synthesis of oxazolidin-2-one derivative (3) The ring-closing reaction to oxazolidin-2-one derivative (3) is performed using N,N-dimethylformaldehyde, N,N-dimethylacetaldehyde. This can be achieved by heating under reflux with sodium carbonate or potassium carbonate in a polar solvent such as diethylene glycol diethyl ether or N-methylpyrrolidone.
ここで得られた1−アミノ−3−ベンジルオキシプロパ
ン−2−オール誘導体(1)、1−(N−アルコキシカ
ルボニル
ルオキシプロパン−2−オール誘導体(2〉及び5−ベ
ンジルオキシメチルオキサゾリジン−2−オン誘導体(
3)はいずれも文献未記載のvfr規化金化合物り、次
に述べる光学純度の高い5−ヒドロキシメチルオキサゾ
リジン−2−オン誘導体(4)を製造する上で重要な中
間体である。The 1-amino-3-benzyloxypropan-2-ol derivative (1), 1-(N-alkoxycarbonyloxypropan-2-ol derivative (2) and 5-benzyloxymethyloxazolidine-2) obtained here -one derivative (
All of 3) are vfr-standardized gold compounds that have not been described in any literature, and are important intermediates in producing the 5-hydroxymethyloxazolidin-2-one derivative (4) with high optical purity described below.
e)5−ヒドロキシメチルオキサゾリジン−2−オン誘
導体(4)の合成
本発明に用いる前記一般式(3)で表わされる5−ベン
ジルオキシメチルオキサゾリジン−2−オン誘導体〈3
)のR1としては水素,炭素数1〜12の直鎖状,分岐
状のアルキル基,アリール基又はアラルキル基が挙げら
れる。具体的には水素,メチル、エチル、プロピル、イ
ソプロピル。e) Synthesis of 5-hydroxymethyloxazolidin-2-one derivative (4) 5-benzyloxymethyloxazolidin-2-one derivative represented by the general formula (3) used in the present invention <3
Examples of R1 in ) include hydrogen, a linear or branched alkyl group having 1 to 12 carbon atoms, an aryl group, or an aralkyl group. Specifically, hydrogen, methyl, ethyl, propyl, and isopropyl.
n−ブチル, sec−ブチル、t−ブチル、ペンチ
ル、ヘキシル、ヘプチル、オクチル、ノニル、デシル、
ウンデシル、ドデシル:フェニル、2−(3,4−ジメ
トキシフェニル〉エチル、R−1−メチル−3−フェニ
ルプロピル等が挙げられる。n-butyl, sec-butyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl,
Examples include undecyl, dodecyl:phenyl, 2-(3,4-dimethoxyphenyl>ethyl, R-1-methyl-3-phenylpropyl).
この5−ベンジルオキシメチルオキサゾリジン−2−オ
ン誘導体(3〉は常法によりパラジウム触媒による水素
化分解で容易に5−ヒドロキシメチルオキサゾリジン−
2−オン誘導体(4)に変換できる。すなわちこの水素
化分解は1〜5atmの水素圧下で例えば0.2〜IO
W/W%活性炭に担持したパラジウム触媒を用いてメタ
ノール、エタノール、アセトン、酢酸エチル、酢酸など
の極性溶媒中で理論量の水素を吸収するまで反応させて
行うことにより高収率で達成できる。This 5-benzyloxymethyloxazolidin-2-one derivative (3) can be easily converted to 5-hydroxymethyloxazolidine-2-one by hydrogenolysis using a palladium catalyst in a conventional manner.
It can be converted into the 2-one derivative (4). That is, this hydrogenolysis is carried out under a hydrogen pressure of 1 to 5 atm, for example, 0.2 to IO.
A high yield can be achieved by carrying out the reaction using a palladium catalyst supported on W/W% activated carbon in a polar solvent such as methanol, ethanol, acetone, ethyl acetate, acetic acid, etc. until the theoretical amount of hydrogen is absorbed.
(発明の効果)
本発明によれば、従来法と比べて、ラセミ化を起すこと
なく、簡単な反応経路で収率よく目的物質を容易に得る
ことができ、副反応を伴うことなく反応させることがで
きる。(Effects of the Invention) According to the present invention, compared to conventional methods, the target substance can be easily obtained in good yield through a simple reaction route without causing racemization, and the reaction can be carried out without side reactions. be able to.
以下実施例をあげて具体的に説明する。The present invention will be specifically explained below with reference to examples.
(実施例)
化合物(0)から本発明の方法により誘導体(4)を得
る実施例を以下順に示す。(Example) Examples of obtaining derivative (4) from compound (0) by the method of the present invention are shown below in order.
実施例
1)誘導体(1)の合成
R− (−)−ベンジルグリシジルエーテル(96%e
e) 49.2gをイソプロピルアミン140(]、
メタノール140g中で5時間加熱還流し、ガスクロマ
トグラフで反応が終了している事を確め、溶媒を減圧留
去し、残漬を減圧蒸留してS− (−)− 1−ベンジ
ルオキシ−3−イソプロピルアミノプロパン−2−オー
ル59. 5(Jを得た。Example 1) Synthesis of derivative (1) R-(-)-benzyl glycidyl ether (96% e
e) 49.2g of isopropylamine 140(],
Heat under reflux in 140 g of methanol for 5 hours, confirm the completion of the reaction using gas chromatography, remove the solvent under reduced pressure, and distill the residue under reduced pressure to obtain S-(-)-1-benzyloxy-3. -isopropylaminopropan-2-ol59. 5 (got J.
収率 89%
bp126〜127℃10. 9Torr[α]習−8
.31” (C=1.06, )夕/−ル)NMR
(CDC13)
δ: 1.07 (6tl, J=7.0H
z 、 CH3 )2、55 〜2.70 (?H,
m,CH)2、72 〜2.88 (2tl,
m, CH2 )3、()8 (2H, b
r S, CH2 >3、47,3.49 (各々l
tl, br s, NH, OH)3、90
(IH, m, CM>4、54 (2
tl, S, CH2 )7、32 (5
tl, S, Ph)このものの光学811度はキラ
ルセルODを用い、ヘキサン:2−プCl/<ノール5
0:2 (v/v)。Yield 89% bp126-127℃10. 9Torr [α] Xi-8
.. 31” (C=1.06, )NMR
(CDC13) δ: 1.07 (6tl, J=7.0H
z, CH3) 2,55 ~ 2.70 (?H,
m, CH)2,72 ~2.88 (2tl,
m, CH2 )3, ()8 (2H, b
r S, CH2 >3, 47, 3.49 (each l
tl, br s, NH, OH)3,90
(IH, m, CM>4, 54 (2
tl, S, CH2 )7, 32 (5
tl, S, Ph) Optical 811 degree of this is determined using Chiralcel OD, hexane:2-Cl/<Nol5
0:2 (v/v).
1、5ml/mill 、λmaX 256nmで分析
し、保持時間(Rt> 8.8, 10.6分に各々
溶出するR体,3体の比より96%eeであることがわ
かった。Analysis was performed at 1 and 5 ml/mill and λmaX 256 nm, and it was found to be 96% ee from the ratio of the R isomer and the 3 isomer eluting at retention times (Rt > 8.8 and 10.6 minutes, respectively).
またR− (−)− 1−ベンジルオキシ−3−クロロ
プロパン−2−オール(96%ee) 18.55gを
イソプロピルアミン30Cl 、メタノール30(]中
で5時間力0熱還流し、炭酸カリウム7、5gを加え更
に2時間撹拌下に加熱還流し、反応混合物をろ過し、ろ
液を減圧濃縮し、残漬を減圧蒸留してS−(−11−ベ
ンジルオキシ−3−イソプロピルアミノプロパン−2−
オール1B.4(lを得た。収率79%2〉誘導体(2
)の合成
5−(−)−1−ベンジルオキシ−3−イソプロピルア
ミノプロパン−2−オール30.0gをアセトン289
.水20gにとかし、炭酸カリウム10.19(1と水
15(]からなる溶液をこれに加え、氷水浴で冷却して
反応液温を10℃以下に保つように撹拌下でクロロ炭酸
エチル16.09(]を滴下した。滴下接受に1時間1
0℃以下で撹拌したのち、酢酸エチルを加えて抽出し、
5−(−)−1−ベンジルオキシ−3−(N−エトキシ
カルボニル)イソプロピルアミノプロパン−2−オール
39.80をほぼ定量的収率で得た。In addition, 18.55 g of R-(-)-1-benzyloxy-3-chloropropan-2-ol (96% ee) was heated under reflux for 5 hours in 30 Cl of isopropylamine and 30 ml of methanol, and 7 g of potassium carbonate was added. The reaction mixture was filtered, the filtrate was concentrated under reduced pressure, and the residue was distilled under reduced pressure to give S-(-11-benzyloxy-3-isopropylaminopropane-2-
All 1B. 4 (l) was obtained. Yield 79% 2> derivative (2
) Synthesis of 30.0 g of 5-(-)-1-benzyloxy-3-isopropylaminopropan-2-ol and 289 g of acetone.
.. Dissolved in 20 g of water, add a solution consisting of 10.19 g of potassium carbonate and 15 g of water, cool in an ice-water bath, and stir while keeping the reaction temperature below 10°C. 09 () was dropped.It took 1 hour to receive the drop.
After stirring at 0°C or lower, extract by adding ethyl acetate,
39.80 of 5-(-)-1-benzyloxy-3-(N-ethoxycarbonyl)isopropylaminopropan-2-ol was obtained in an almost quantitative yield.
[α]習 −9,96° (C=1.09.メタノール
〉I R(neat) 3452.1696cm−1
HMR(CDO23>
δ:1.15 (6H。[α] Xi -9,96° (C=1.09.methanol>IR(neat) 3452.1696cm-1
HMR(CDO23>δ:1.15 (6H.
1.29 (3H。1.29 (3H.
3.30 (2H。3.30 (2H.
3.48 (2H。3.48 (2H.
3.92 (1M。3.92 (1M.
J=7.0Hz 、 CH3)
t、 J=7.0Hz 、 CH3)br s、 C
H2)
br s、 CH2)
m、CH)
4.15 (2H,Q、 J=7.0tl
Z 、 CH2)4.07〜/1.25 (IH,m
、CH)4.2〜4.5 (11,br s、 0
H)4.56 (2N、 S、 CH2)
7.34 (5H,S、 Ph)このものの
光学純度はキラルセルODを用い、ヘキサン=2−プロ
パツール500:3 (V/V)。J=7.0Hz, CH3) t, J=7.0Hz, CH3)br s, C
H2) br s, CH2) m, CH) 4.15 (2H,Q, J=7.0tl
Z, CH2) 4.07~/1.25 (IH, m
, CH) 4.2-4.5 (11, br s, 0
H) 4.56 (2N, S, CH2)
7.34 (5H, S, Ph) The optical purity of this product was determined using Chiralcel OD, hexane = 2-propertool 500:3 (V/V).
1.5d/min 、λmax 256nmで口PLC
分析を行いRt各々38.43分に溶出する8体、R体
の比率より95.8%eeであることがわかった。1.5d/min, λmax 256nm
Analysis was conducted and the ratio of 8 isomers and R isomers eluting at Rt of 38.43 minutes revealed that the ee was 95.8%.
3)誘導体(3)の合成
S−(−)−1−ベンジルオキシ−3−(N−エトキシ
カルボニル)イソプロピルアミノプロパン−2−オール
35gを炭酸ナトリウム20(lとN、N−ジメチルホ
ルムアルデヒド50−中で2日間還流撹拌し、反応の終
了をIRスペクトルで確認し、無機塩をろ過して除去し
、溶媒を減圧留去してS−(+)−5−ベンジルオキシ
メチル−プロピルオキサゾリジン−2−オン29. 4
(]をほぼ定量的収率で得た。3) Synthesis of derivative (3) 35 g of S-(-)-1-benzyloxy-3-(N-ethoxycarbonyl)isopropylaminopropan-2-ol was mixed with 20 g of sodium carbonate and 50 g of N,N-dimethylformaldehyde. The completion of the reaction was confirmed by IR spectrum, the inorganic salt was filtered off, and the solvent was distilled off under reduced pressure to give S-(+)-5-benzyloxymethyl-propyloxazolidine-2. -on 29.4
(] was obtained in almost quantitative yield.
[α]習 +36. 23° (C=1.06,メタノ
ール〉IR (neat) 1746. 1256.
1050cm−1HMR (CDα3)
δ:1.14 (6N, d。[α] Xi +36. 23° (C=1.06, methanol>IR (neat) 1746. 1256.
1050cm-1HMR (CDα3) δ: 1.14 (6N, d.
3、33 (1N, dd。3, 33 (1N, dd.
3、51 (IH, t。3, 51 (IH, t.
3、61 (2H, d。3, 61 (2H, d.
4、08 (IH,Sept。4, 08 (IH, Sept.
4、50 〜4.68(IH, m, CH)4、5
7 (2H, S, CH2 )7、32
(5H, s, Ph)このものの光学純度は
キラルセルODを用い、ヘキサン= 2−プロパツール
50:2 (v/v)。4,50 ~4.68 (IH, m, CH) 4,5
7 (2H, S, CH2)7, 32
(5H, s, Ph) The optical purity of this product was determined using Chiralcel OD, and hexane = 2-propertool 50:2 (v/v).
1、5d/min 、λmaX 256nmで日PLC
分析した。1.5d/min, λmax 256nm, PLC
analyzed.
Rt各々36. 48分に溶出するR体,8体の比より
95、7%eeであることがわかった。Rt each 36. From the ratio of the R and 8 forms eluting at 48 minutes, it was found that the ee was 95.7%.
4)誘導体(4)の製造
S− (+)− 5−ベンジルオキシメチル−3イソプ
ロピルオキサゾリジン−2−オン26. 67(Jを5
%活性炭に担持したPd触媒2.06gと酢酸iog。4) Preparation of derivative (4) S- (+)-5-benzyloxymethyl-3isopropyloxazolidin-2-one26. 67 (J 5
% activated carbon supported Pd catalyst and 2.06 g of acetic acid iog.
J=6.8tlz 、 CH3 )
J=6.0, 8.8Hz, CH)
J=8.8Hz 、 CH)
J=6.OHz 、 CH2 )
J=6.8Hz 、 CH)
メタノール100rdl中3kCI/rfflの水素圧
下で水素を吸収しなくなるまで反応させた。反応終了後
触媒をろ過して除き、溶媒を減圧留去し、酢酸エチルを
加え、飽和NaHCO:+水溶液で中和し、溶媒を留去
し、エーテルで再結晶してS− (十)−5−ヒドロキ
シメチル−3−イソプロピルオキサゾリジン−2−オン
15.20i;lを得た。収率96.8%mp 5
5〜56℃
[α]習 +57.2° (C=1.18,CHCi3
)( lit.mp55〜56℃,[α] ”fj +
57.1。J=6.8tlz, CH3) J=6.0, 8.8Hz, CH) J=8.8Hz, CH) J=6. OHz, CH2) J=6.8Hz, CH) The reaction was carried out under a hydrogen pressure of 3 kCI/rffl in 100 rdl of methanol until no more hydrogen was absorbed. After the reaction, the catalyst was removed by filtration, the solvent was distilled off under reduced pressure, ethyl acetate was added, neutralized with saturated NaHCO: + aqueous solution, the solvent was distilled off, and recrystallized with ether to give S-(10)- 15.20 i;l of 5-hydroxymethyl-3-isopropyloxazolidin-2-one was obtained. Yield 96.8%mp5
5~56℃ [α] +57.2° (C=1.18, CHCi3
)( lit.mp55~56℃, [α] ”fj +
57.1.
( C=1.17, CHCj!3) 、 Chem.
Pharm.Bu」五12)、3593(1981))
NMR (CDα3〉
δ:1.18 (6H, d。(C=1.17, CHCj!3), Chem.
Pharm. Bu'' 512), 3593 (1981)) NMR (CDα3> δ: 1.18 (6H, d.
3、43 (1)1,dd。3, 43 (1) 1, dd.
3、52 (IH, t。3, 52 (IH, t.
3、65 (1M, dd。3,65 (1M, dd.
3、86 (IH, br dd。3, 86 (IH, br dd.
4、08 (IH,Set)t。4, 08 (IH, Set) t.
4、59 (IH, m, CH)J=6.8H
z 、 CH3 )
J=8.8, 6.6Hz, CH)
J=8.8Hz 、 CH)
J=−12.5,4.2Hz, CH)J=−12.5
,3.3Hz, CH)J=6.8Hz 、 CH)4, 59 (IH, m, CH) J=6.8H
z, CH3) J=8.8, 6.6Hz, CH) J=8.8Hz, CH) J=-12.5, 4.2Hz, CH) J=-12.5
, 3.3Hz, CH) J=6.8Hz, CH)
Claims (1)
_1_2のアルキル基、アリール基又はアラルキル基を
表わし、*は不斉炭素を表わす。)で表わされる5−ベ
ンジルオキシメチルオキサゾリジン−2−オン誘導体を
パラジウム触媒の存在下水素化分解することを特徴とす
る、一般式(4) ▲数式、化学式、表等があります▼(4) (式中R^1、*は上記と同じ。)で表わされる光学活
性オキサゾリジノン誘導体の製法。[Claims] General formula (3) ▲Mathematical formulas, chemical formulas, tables, etc.▼(3) (In the formula, ph is a phenyl group, R^1 is hydrogen, C_1 to C
_1_2 represents an alkyl group, aryl group or aralkyl group, and * represents an asymmetric carbon. ) is characterized by hydrogenolyzing the 5-benzyloxymethyloxazolidin-2-one derivative represented by (4) in the presence of a palladium catalyst. A method for producing an optically active oxazolidinone derivative represented by the formula (R^1, * is the same as above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1179493A JPH0344381A (en) | 1989-07-12 | 1989-07-12 | Optically active oxazolidinone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1179493A JPH0344381A (en) | 1989-07-12 | 1989-07-12 | Optically active oxazolidinone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0344381A true JPH0344381A (en) | 1991-02-26 |
Family
ID=16066790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1179493A Pending JPH0344381A (en) | 1989-07-12 | 1989-07-12 | Optically active oxazolidinone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0344381A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58105966A (en) * | 1981-12-11 | 1983-06-24 | ジ−・デイ・サ−ル・アンド・コンパニ− | Novel 5-substituted isoquinoline compound |
| JPS6036471A (en) * | 1983-08-08 | 1985-02-25 | Kanegafuchi Chem Ind Co Ltd | Preparation of optically active oxazolidinone derivative |
| JPS6067470A (en) * | 1983-09-22 | 1985-04-17 | Kanegafuchi Chem Ind Co Ltd | Production of optically active oxazolidin-2-one derivative |
-
1989
- 1989-07-12 JP JP1179493A patent/JPH0344381A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58105966A (en) * | 1981-12-11 | 1983-06-24 | ジ−・デイ・サ−ル・アンド・コンパニ− | Novel 5-substituted isoquinoline compound |
| JPS6036471A (en) * | 1983-08-08 | 1985-02-25 | Kanegafuchi Chem Ind Co Ltd | Preparation of optically active oxazolidinone derivative |
| JPS6067470A (en) * | 1983-09-22 | 1985-04-17 | Kanegafuchi Chem Ind Co Ltd | Production of optically active oxazolidin-2-one derivative |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4358295B2 (en) | Process for producing benzoxazine derivative and its intermediate | |
| CA2027783C (en) | 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy | |
| JPH044311B2 (en) | ||
| EP0835254B1 (en) | Oxazolidinone derivatives, their preparation and therapeutical use | |
| CN101563329A (en) | Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione) | |
| EP0511031B1 (en) | 3-Aryl-oxazolidinon derivatives, process for their preparation and their use in therapeutics | |
| JPH0344381A (en) | Optically active oxazolidinone derivative | |
| FR2634207A1 (en) | [(4-Piperidyl)methyl]benzazepine derivatives, their preparation and their application in therapeutics | |
| FR2601008A1 (en) | PROCESS FOR STEREOSPECIFIC SYNTHESIS OF INDOLE DERIVATIVES | |
| US4946974A (en) | Optically active derivatives of glycidol | |
| JPH0344363A (en) | Optically active amino compound and preparation thereof | |
| EP1501516B1 (en) | A process for the preparation of benazepril hydrochloride | |
| RU2295521C2 (en) | Photochrome oxazine compounds and methods for their synthesis | |
| JPH0344380A (en) | Optically active amino compound and production thereof | |
| JP2832479B2 (en) | Stereochemical inversion method of optically active styrene oxide and preparation of optically active glycol derivative | |
| JPH0344358A (en) | Optically active amino compound and production thereof | |
| JP3159518B2 (en) | Preparation of amino-substituted spiro compounds | |
| EP2540717A1 (en) | Lamivudine oxalate and preparation method thereof | |
| US5344947A (en) | Optically active derivatives of glycidol | |
| US6084107A (en) | Intermediates for making HIV-protease inhibitors | |
| KR100355756B1 (en) | Method for manufacturing a S-ofloxacin | |
| WO2023100110A1 (en) | Process for preparing brivaracetam | |
| JPH04270272A (en) | Production of aminoalkylmorpholine derivative | |
| BE837320A (en) | 3-AMINO-1,2-PROPANODIOL ETHER DERIVATIVES | |
| FR2794123A1 (en) | PREPARATION OF CAMPTOTHECIN AND NOTHAPODYTINE DERIVATIVES |